Health Condition 1: N181- Chronic kidney disease, stage 1 Health Condition 2: N182- Chronic kidney disease, stage 2 (mild) Health Condition 3: N183- Chronic kidney disease, stage 3 (moderate) Health Condition 4: N184- Chronic kidney disease, stage 4 (severe) Health Condition 5: N185- Chronic kidney disease, stage 5 Health Condition 6: N189- Chronic kidney disease, unspecified Health Condition 7: N186- End stage renal disease
Conditions
Interventions
Intervention1: Anti-inflammatory diet for chronic kidney disease: Intervention type: Anti-inflammatory dietary pattern for chronic kidney disease patients (per dietary inflammatory index score).
De
Sponsors
Prathiksha R Bhat
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed Chronic Kidney Disease patients with or without diabetes, hypertension and cardiovascular disease.
Exclusion criteria
Exclusion criteria: Patients on dialysis, renal transplant recipients, with physiological alterations such as pregnancy/lactation, physical impairment/disabilities, recent history of trauma, infection, major surgery or any other chronic catabolic illness such as COPD, cancer etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum creatinine and estimated glomerular filtration rate (CKD-EPI equation, 2009)Timepoint: 0th and 6th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Body composition analysis by a multi-frequency bio-impedance-based analyzer, InBody 770Timepoint: 0th, 3rd and 6th week;Inflammatory marker - CRP by LEIT methodTimepoint: 0th, 3rd and 6th week;Lipid profile - Triglycerides, cholesterol, HDL-C (enzymatic kit methods), calculated LDL-C (Martin Hopkins equation)Timepoint: 0th, 3rd and 6th week;Oxidative stress marker - Malondialdehyde by TBARS methodTimepoint: 0th, 3rd and 6th week;Quality of Life - KDQOL-36 SF questionnaireTimepoint: 0th and 6th week;Serum creatinine and estimated glomerular filtration rate (CKD-EPI equation, 2009)Timepoint: 3rd week;Serum electrolytes, phosphorous, calcium, protein, albumin (kit methods)Timepoint: 0th, 3rd and 6th week;Total antioxidant capacity - FRAP and uric acid independent FRAP assayTimepoint: 0th, 3rd and 6th week | — |
Countries
India
Contacts
Public ContactPrathiksha R Bhat
University of Mysore
Outcome results
None listed